(KHC) Kraft Heinz - Ratings and Ratios
Condiments, Cheese, Meals, Beverages, Coffee
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 6.63% |
| Yield on Cost 5y | 5.73% |
| Yield CAGR 5y | 0.00% |
| Payout Consistency | 95.1% |
| Payout Ratio | 58.0% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 19.5% |
| Value at Risk 5%th | 32.0% |
| Relative Tail Risk | -0.25% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.76 |
| Alpha | -23.71 |
| CAGR/Max DD | -0.33 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.345 |
| Beta | 0.262 |
| Beta Downside | 0.079 |
| Drawdowns 3y | |
|---|---|
| Max DD | 36.34% |
| Mean DD | 17.56% |
| Median DD | 17.12% |
Description: KHC Kraft Heinz December 17, 2025
The Kraft Heinz Company (NASDAQ: KHC) manufactures and markets a broad portfolio of food and beverage products-including condiments, cheese, meals, meats, coffee, and snack items-under iconic brands such as Kraft, Heinz, Oscar Mayer, Philadelphia, and Lunchables. Its distribution network spans company-owned sales forces, independent brokers, and a wide array of retail and food-service channels, from grocery chains and mass merchants to e-commerce platforms and institutional accounts.
Key performance indicators (as of FY 2024) show revenue of roughly $27 billion with an adjusted EBITDA margin near 13 %, reflecting modest pricing power amid rising commodity costs for dairy and meat. The packaged-foods sector is currently pressured by inflation-driven consumer price sensitivity and a shift toward private-label and “better-for-you” products, while supply-chain resilience and scale remain competitive advantages for KHC.
For a deeper quantitative view, consider reviewing ValueRay’s analyst toolkit to extend your research.
Piotroski VR‑10 (Strict, 0-10) 2.5
| Net Income (-4.37b TTM) > 0 and > 6% of Revenue (6% = 1.51b TTM) |
| FCFTA 0.04 (>2.0%) and ΔFCFTA 1.06pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 4.47% (prev 1.81%; Δ 2.66pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.05 (>3.0%) and CFO 4.47b > Net Income -4.37b (YES >=105%, WARN >=100%) |
| NO Net Debt/EBITDA fails (EBITDA <= 0) |
| Current Ratio 1.13 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (1.19b) change vs 12m ago -1.98% (target <= -2.0% for YES) |
| Gross Margin 33.65% (prev 34.60%; Δ -0.95pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 29.56% (prev 29.50%; Δ 0.06pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -5.86 (EBITDA TTM -4.67b / Interest Expense TTM 958.0m) >= 6 (WARN >= 3) |
Altman Z'' -0.76
| (A) 0.01 = (Total Current Assets 9.99b - Total Current Liabilities 8.86b) / Total Assets 81.69b |
| (B) -0.06 = Retained Earnings (Balance) -5.28b / Total Assets 81.69b |
| (C) -0.07 = EBIT TTM -5.62b / Avg Total Assets 85.13b |
| (D) -0.19 = Book Value of Equity -7.65b / Total Liabilities 40.12b |
| Total Rating: -0.76 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 37.69
| 1. Piotroski 2.50pt |
| 2. FCF Yield 7.71% |
| 3. FCF Margin 14.43% |
| 4. Debt/Equity 0.51 |
| 5. Debt/Ebitda -4.08 |
| 6. ROIC - WACC (= -10.83)% |
| 7. RoE -9.62% |
| 8. Rev. Trend -35.06% |
| 9. EPS Trend -8.21% |
What is the price of KHC shares?
Over the past week, the price has changed by -1.55%, over one month by -4.25%, over three months by -5.90% and over the past year by -16.29%.
Is KHC a buy, sell or hold?
- Strong Buy: 3
- Buy: 0
- Hold: 16
- Sell: 2
- Strong Sell: 2
What are the forecasts/targets for the KHC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 27.1 | 12.4% |
| Analysts Target Price | 27.1 | 12.4% |
| ValueRay Target Price | 24.2 | 0.3% |
KHC Fundamental Data Overview December 21, 2025
P/E Forward = 9.6154
P/S = 1.1529
P/B = 0.6999
P/EG = 1.0012
Beta = 0.073
Revenue TTM = 25.16b USD
EBIT TTM = -5.62b USD
EBITDA TTM = -4.67b USD
Long Term Debt = 19.29b USD (from longTermDebt, last quarter)
Short Term Debt = 1.91b USD (from shortTermDebt, last quarter)
Debt = 21.19b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 19.05b USD (from netDebt column, last quarter)
Enterprise Value = 47.07b USD (29.01b + Debt 21.19b - CCE 3.13b)
Interest Coverage Ratio = -5.86 (Ebit TTM -5.62b / Interest Expense TTM 958.0m)
FCF Yield = 7.71% (FCF TTM 3.63b / Enterprise Value 47.07b)
FCF Margin = 14.43% (FCF TTM 3.63b / Revenue TTM 25.16b)
Net Margin = -17.35% (Net Income TTM -4.37b / Revenue TTM 25.16b)
Gross Margin = 33.65% ((Revenue TTM 25.16b - Cost of Revenue TTM 16.70b) / Revenue TTM)
Gross Margin QoQ = 31.91% (prev 34.13%)
Tobins Q-Ratio = 0.58 (Enterprise Value 47.07b / Total Assets 81.69b)
Interest Expense / Debt = 1.13% (Interest Expense 240.0m / Debt 21.19b)
Taxrate = 24.04% (194.0m / 807.0m)
NOPAT = -4.27b (EBIT -5.62b * (1 - 24.04%)) [loss with tax shield]
Current Ratio = 1.13 (Total Current Assets 9.99b / Total Current Liabilities 8.86b)
Debt / Equity = 0.51 (Debt 21.19b / totalStockholderEquity, last quarter 41.45b)
Debt / EBITDA = -4.08 (negative EBITDA) (Net Debt 19.05b / EBITDA -4.67b)
Debt / FCF = 5.25 (Net Debt 19.05b / FCF TTM 3.63b)
Total Stockholder Equity = 45.36b (last 4 quarters mean from totalStockholderEquity)
RoA = -5.34% (Net Income -4.37b / Total Assets 81.69b)
RoE = -9.62% (Net Income TTM -4.37b / Total Stockholder Equity 45.36b)
RoCE = -8.69% (EBIT -5.62b / Capital Employed (Equity 45.36b + L.T.Debt 19.29b))
RoIC = -6.43% (negative operating profit) (NOPAT -4.27b / Invested Capital 66.33b)
WACC = 4.40% (E(29.01b)/V(50.20b) * Re(6.98%) + D(21.19b)/V(50.20b) * Rd(1.13%) * (1-Tc(0.24)))
Discount Rate = 6.98% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -81.65 | Cagr: -0.81%
[DCF Debug] Terminal Value 79.55% ; FCFE base≈3.38b ; Y1≈3.70b ; Y5≈4.70b
Fair Price DCF = 69.10 (DCF Value 81.79b / Shares Outstanding 1.18b; 5y FCF grow 10.77% → 3.0% )
EPS Correlation: -8.21 | EPS CAGR: -6.66% | SUE: 1.05 | # QB: 2
Revenue Correlation: -35.06 | Revenue CAGR: -1.93% | SUE: -0.11 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.59 | Chg30d=-0.002 | Revisions Net=-9 | Analysts=11
EPS next Year (2026-12-31): EPS=2.52 | Chg30d=-0.010 | Revisions Net=-20 | Growth EPS=-0.6% | Growth Revenue=-0.0%
Additional Sources for KHC Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle